A mystery solved

Abbasi, Hina; Bell, Stephen; Stewart, William; Neelakantan, Asha; Webb, Stewart

doi:10.1136/practneurol-2013-000638

Cited by 2 publications

(1 citation statement)

References 1 publication

(1 reference statement)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While the utility of verapamil is questionable, these cases suggest that IVL of the pituitary and pons responds well to R-CHOP alone. Despite this, a case of IVL involving both the brain and spinal cord initially responded to five cycles of R-CHOP, but after 5 months, the patient experienced CNS recurrence with neurological symptoms, suggesting that R-CHOP alone may not be sufficient treatment for IVL with extensive CNS involvement [ 32 ].…”

Section: Therapeutic Interventionsmentioning

confidence: 99%

Intravascular Lymphoma in the CNS: Options for Treatment

Nizamutdinov

Patel

Huang

et al. 2017

Curr Treat Options Neurol

View full text Add to dashboard Cite

Purpose of review The purpose of this review was to discuss therapeutic manipulations and effective current interventions available to treat intravascular lymphoma in the central nervous system. Recent findings Patients experienced resolution and remission of disease for 14 months and up to 2 years after eight cycles of R-CHOP and four courses of intrathecal therapy with MTX, cytarabine, and prednisolone. Intravascular use of unfractionated heparin during therapy may contribute to better outcome. Summary Series of therapeutic avenues were analyzed and compared. The effective current treatment of intravascular lymphoma in the CNS is considered to be a combinational intrathecal methotrexate-based chemotherapy with rituximab. Since intrathecal administration bypasses the blood–brain barrier, lower doses can be given, which thereby minimizes systemic toxicity. Practical use of intrathecal chemotherapy is also justified for prophylaxis in intravascular lymphoma-diagnosed patients without CNS involvement.

show abstract

Section: Therapeutic Interventionsmentioning

confidence: 99%